This split, trial versus realworld reporting, is typical for side effects that are uncomfortable but not usually dangerous
PMID: 9849822 The Discovery of Growth Hormone-Releasing Hormone: An Update Jett, L., Lger, R., Thibaudeau, K., Benquet, C., Robitaille, M., Pellerin, I., Paradis, V., van Wyk, P., Pham, K., & Bridon, D
The Role of GLP-1 Receptor Agonists in IBD-Related Surgery and IBD-Related Complications of Inflammatory Bowel Disease Among Patients With Metabolic Comorbidities: A Systematic Review and Meta-Analysis
Pay upfront in full
For anyone considering tirzepatide, individualized care and ongoing oversight are essential to achieving safe and sustainable results